A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm
Clinical trial NCT04503551 · COMPLETED
Trial details
- NCT number
- NCT04503551
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2022-10-03
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.